Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Prymula

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Vaccine|May 4, 2010
Comparison of immunogenicity and safety between two paediatric TBE vaccinesEva Maria Pöllabauer, Borislava G Pavlova, Alexandra Löw-Baselli, et al.
Vaccine|October 6, 2011
Rubella revisited: where are we on the road to disease elimination in Central Europe?Vytautas Usonis, Ioana Anca, Francis André, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 28, 2013
Rotavirus vaccination in central EuropeZsófia Mészner, Ioana Anca, Francis André, et al.
Public Health Reviews|February 10, 2025
Filling the Gap to Address Vaccine Hesitancy in EuropeTiago Correia, Anabela da Conceição Pereira, Henrique Barros, et al.
The Pediatric Infectious Disease Journal|January 13, 2016
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of AgeMatthew D Snape, Merryn Voysey, Adam Finn, et al.
Human Vaccines & Immunotherapeutics|January 8, 2013
Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)Dace Zavadska, Ioana Anca, Francis André, et al.
Vaccine|January 10, 2012
Adult vaccination in 11 Central European countries - calendars are not just for childrenRoman Chlibek, Ioana Anca, Francis André, et al.
Vaccine|July 29, 2018
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre studyAlfonso Carmona Martinez, Roman Prymula, Mariano Miranda Valdivieso, et al.
Vaccine|April 16, 2021
Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countriesRoman Prymula, Michael Povey, Jerzy Brzostek, et al.
JAMA|February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialNicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Vaccine|May 4, 2010
Comparison of immunogenicity and safety between two paediatric TBE vaccinesEva Maria Pöllabauer, Borislava G Pavlova, Alexandra Löw-Baselli, et al.
Vaccine|October 6, 2011
Rubella revisited: where are we on the road to disease elimination in Central Europe?Vytautas Usonis, Ioana Anca, Francis André, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 28, 2013
Rotavirus vaccination in central EuropeZsófia Mészner, Ioana Anca, Francis André, et al.
Public Health Reviews|February 10, 2025
Filling the Gap to Address Vaccine Hesitancy in EuropeTiago Correia, Anabela da Conceição Pereira, Henrique Barros, et al.
The Pediatric Infectious Disease Journal|January 13, 2016
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of AgeMatthew D Snape, Merryn Voysey, Adam Finn, et al.
Human Vaccines & Immunotherapeutics|January 8, 2013
Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)Dace Zavadska, Ioana Anca, Francis André, et al.
Vaccine|January 10, 2012
Adult vaccination in 11 Central European countries - calendars are not just for childrenRoman Chlibek, Ioana Anca, Francis André, et al.
Vaccine|July 29, 2018
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre studyAlfonso Carmona Martinez, Roman Prymula, Mariano Miranda Valdivieso, et al.
Vaccine|April 16, 2021
Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countriesRoman Prymula, Michael Povey, Jerzy Brzostek, et al.
JAMA|February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialNicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
Pageof 8